» Articles » PMID: 16574954

Diagnostic Application of Flow Cytometric Characteristics of CD34+ Cells in Low-grade Myelodysplastic Syndromes

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2006 Apr 1
PMID 16574954
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

The diagnosis of myelodysplastic syndromes (MDS) without an increase in blasts and ringed sideroblasts (low-grade MDS without ringed sideroblasts [LGw/oRS]) may be problematic because dysplastic features are not specific to MDS and approximately 50% of patients with LGw/oRS lack chromosomal aberrations. Here, we report the usefulness of flow cytometric characteristics of CD34(+) cells for LGw/oRS diagnosis. Bone marrow cells from LGw/oRS patients and controls (eg, cytopenic individuals without MDS) were analyzed using 4-color flow cytometry (FCM). We objectively determined reference ranges of 13 parameters related to CD34(+) cells with data from controls. In LGw/oRS patients, various abnormalities of CD34(+) cells-eg, decrease in CD34(+) B-cell precursors, aberrant expression or overexpression of various antigens on CD34(+) myeloblasts-were observed. We constructed a reproducible, flow cytometric scoring system for LGw/oRS diagnosis. High scores were observed in 16 of 27 LGw/oRS patients, regardless of the presence or absence of chromosomal aberrations, but not in any of the 90 controls. Among LGw/oRS patients with chromosomal aberrations, patients with trisomy 8 or del20(q) had low FCM scores (P = .002). As a result, most LGw/oRS patients were identified based on high FCM score, chromosomal aberration, or both.

Citing Articles

Immunophenotyping myelodysplastic neoplasms: the role of flow cytometry in the molecular classification era.

Verigou E, Chatzilygeroudi T, Lazaris V, de Lastic A, Symeonidis A Front Oncol. 2024; 14:1447001.

PMID: 39544295 PMC: 11560873. DOI: 10.3389/fonc.2024.1447001.


The role of flow cytometry in the classification of myeloid disorders.

Saft L Pathologie (Heidelb). 2023; 44(Suppl 3):164-175.

PMID: 37991530 PMC: 10739577. DOI: 10.1007/s00292-023-01272-8.


Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group.

Porwit A, Bene M, Duetz C, Matarraz S, Oelschlaegel U, Westers T Cytometry B Clin Cytom. 2022; 104(1):27-50.

PMID: 36537621 PMC: 10107708. DOI: 10.1002/cyto.b.22108.


The Impact of Clonal Hierarchy and Heterogeneity on Phenotypic Manifestations of Myelodysplastic Neoplasms.

El Hussein S, Loghavi S Cancers (Basel). 2022; 14(22).

PMID: 36428782 PMC: 9688198. DOI: 10.3390/cancers14225690.


Concurrent Waldenstrom's Macroglobulinemia and Myelodysplastic Syndrome with a Sequent t(10;13)(p13;q22) Translocation.

DeRosa P, Roche K, Nava V, Singh S, Liu M, Agarwal A Curr Oncol. 2022; 29(7):4587-4592.

PMID: 35877223 PMC: 9325113. DOI: 10.3390/curroncol29070363.